Briviact 50 MG tablet 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F5QZW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,477
Award facts
- Contract value 100% obligated
- $3,476.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency on January 20, 2026, for Briviact 50 mg tablets (60-count). The contract is valued at $3,476.66 with a firm fixed price structure and an ultimate completion date of January 21, 2026. This award was competitively awarded with no set-aside designation and represents a task order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle valued through December 2026. The parent company is Cencora, Inc., which does business as AmerisourceBergen.
As a child delivery order under the DLA Troop Support Medical IDC, this pharmaceutical supply is part of the Defense Logistics Agency's medical supply chain supporting military healthcare programs. AmerisourceBergen's extensive federal contract portfolio demonstrates its critical role in supplying specialty medications, brand-name and generic drugs, and specialized medical commodities across multiple therapeutic domains to military treatment facilities and other federal healthcare systems worldwide. The firm fixed price and rapid completion timeline reflect the standardized procurement structure typical of DLA pharmaceutical delivery orders within the broader military medical supply network.
Quick answers
Who was awarded contract SPE2DR26F5QZW?
SPE2DR26F5QZW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26F5QZW worth?
The government has obligated $3,477 on SPE2DR26F5QZW.
Is contract SPE2DR26F5QZW an order under another contract?
Yes. SPE2DR26F5QZW is a delivery order under SPE2DR25D2013, an indefinite delivery contract.
Was contract SPE2DR26F5QZW competed?
The extent of competition for SPE2DR26F5QZW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award